SLAMF1 (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "SLAMF1" in English language version.

Last modified: 06:34:25, 3 August 2026 (UTC)

Ref.Un. Ref.Website

Global rank English rank

4417nih.gov

5^th place

289doi.org

2^nd place

132semanticscholar.org

15^th place

8^th place

121zenodo.org

737^th place

426^th place

62ensembl.org

630^th place

326^th place

11adsabs.harvard.edu

14^th place

9^th place

adsabs.harvard.edu (Global: 14^th place; English: 9^th place)

ui.adsabs.harvard.edu

Cocks BG, Chang CC, Carballido JM, Yssel H, de Vries JE, Aversa G (July 1995). "A novel receptor involved in T-cell activation". Nature. 376 (6537): 260–263. Bibcode:1995Natur.376..260C. doi:10.1038/376260a0. PMID 7617038. S2CID 4319295.

doi.org (Global: 2^nd place; English: 2^nd place)

Cocks BG, Chang CC, Carballido JM, Yssel H, de Vries JE, Aversa G (July 1995). "A novel receptor involved in T-cell activation". Nature. 376 (6537): 260–263. Bibcode:1995Natur.376..260C. doi:10.1038/376260a0. PMID 7617038. S2CID 4319295.
Gordiienko I, Shlapatska L, Kovalevska L, Sidorenko SP (July 2019). "SLAMF1/CD150 in hematologic malignancies: Silent marker or active player?". Clinical Immunology. 204: 14–22. doi:10.1016/j.clim.2018.10.015. PMID 30616923. S2CID 58586790.
Farhangnia P, Ghomi SM, Mollazadehghomi S, Nickho H, Akbarpour M, Delbandi AA (2023-05-11). "SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy". Frontiers in Immunology. 14 1174138. doi:10.3389/fimmu.2023.1174138. PMC 10213746. PMID 37251372.
Schwartz AM, Putlyaeva LV, Covich M, Klepikova AV, Akulich KA, Vorontsov IE, et al. (October 2016). "Early B-cell factor 1 (EBF1) is critical for transcriptional control of SLAMF1 gene in human B cells". Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1859 (10): 1259–1268. doi:10.1016/j.bbagrm.2016.07.004. PMID 27424222.
Fouquet G, Marcq I, Debuysscher V, Bayry J, Rabbind Singh A, Bengrine A, et al. (March 2018). "Signaling lymphocytic activation molecules Slam and cancers: friends or foes?". Oncotarget. 9 (22): 16248–16262. doi:10.18632/oncotarget.24575. PMC 5882332. PMID 29662641.
Dragovich MA, Mor A (July 2018). "The SLAM family receptors: Potential therapeutic targets for inflammatory and autoimmune diseases". Autoimmunity Reviews. 17 (7): 674–682. doi:10.1016/j.autrev.2018.01.018. PMC 6508580. PMID 29729453.
Wu N, Veillette A (February 2016). "SLAM family receptors in normal immunity and immune pathologies". Current Opinion in Immunology. 38: 45–51. doi:10.1016/j.coi.2015.11.003. PMID 26682762.
van Driel BJ, Liao G, Engel P, Terhorst C (2016-01-20). "Responses to Microbial Challenges by SLAMF Receptors". Frontiers in Immunology. 7: 4. doi:10.3389/fimmu.2016.00004. PMC 4718992. PMID 26834746.
de Vries RD, Duprex WP, de Swart RL (February 2015). "Morbillivirus infections: an introduction". Viruses. 7 (2): 699–706. doi:10.3390/v7020699. PMC 4353911. PMID 25685949.

ensembl.org (Global: 630^th place; English: 326^th place)

may2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000117090 – Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000015316 – Ensembl, May 2017

nih.gov (Global: 5^th place; English: 5^th place)

pubmed.ncbi.nlm.nih.gov

Cocks BG, Chang CC, Carballido JM, Yssel H, de Vries JE, Aversa G (July 1995). "A novel receptor involved in T-cell activation". Nature. 376 (6537): 260–263. Bibcode:1995Natur.376..260C. doi:10.1038/376260a0. PMID 7617038. S2CID 4319295.
Gordiienko I, Shlapatska L, Kovalevska L, Sidorenko SP (July 2019). "SLAMF1/CD150 in hematologic malignancies: Silent marker or active player?". Clinical Immunology. 204: 14–22. doi:10.1016/j.clim.2018.10.015. PMID 30616923. S2CID 58586790.
Farhangnia P, Ghomi SM, Mollazadehghomi S, Nickho H, Akbarpour M, Delbandi AA (2023-05-11). "SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy". Frontiers in Immunology. 14 1174138. doi:10.3389/fimmu.2023.1174138. PMC 10213746. PMID 37251372.
Schwartz AM, Putlyaeva LV, Covich M, Klepikova AV, Akulich KA, Vorontsov IE, et al. (October 2016). "Early B-cell factor 1 (EBF1) is critical for transcriptional control of SLAMF1 gene in human B cells". Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1859 (10): 1259–1268. doi:10.1016/j.bbagrm.2016.07.004. PMID 27424222.
Fouquet G, Marcq I, Debuysscher V, Bayry J, Rabbind Singh A, Bengrine A, et al. (March 2018). "Signaling lymphocytic activation molecules Slam and cancers: friends or foes?". Oncotarget. 9 (22): 16248–16262. doi:10.18632/oncotarget.24575. PMC 5882332. PMID 29662641.
Dragovich MA, Mor A (July 2018). "The SLAM family receptors: Potential therapeutic targets for inflammatory and autoimmune diseases". Autoimmunity Reviews. 17 (7): 674–682. doi:10.1016/j.autrev.2018.01.018. PMC 6508580. PMID 29729453.
Wu N, Veillette A (February 2016). "SLAM family receptors in normal immunity and immune pathologies". Current Opinion in Immunology. 38: 45–51. doi:10.1016/j.coi.2015.11.003. PMID 26682762.
van Driel BJ, Liao G, Engel P, Terhorst C (2016-01-20). "Responses to Microbial Challenges by SLAMF Receptors". Frontiers in Immunology. 7: 4. doi:10.3389/fimmu.2016.00004. PMC 4718992. PMID 26834746.
de Vries RD, Duprex WP, de Swart RL (February 2015). "Morbillivirus infections: an introduction". Viruses. 7 (2): 699–706. doi:10.3390/v7020699. PMC 4353911. PMID 25685949.

ncbi.nlm.nih.gov

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Entrez Gene: SLAMF1 signaling lymphocytic activation molecule family member 1".
Farhangnia P, Ghomi SM, Mollazadehghomi S, Nickho H, Akbarpour M, Delbandi AA (2023-05-11). "SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy". Frontiers in Immunology. 14 1174138. doi:10.3389/fimmu.2023.1174138. PMC 10213746. PMID 37251372.
Fouquet G, Marcq I, Debuysscher V, Bayry J, Rabbind Singh A, Bengrine A, et al. (March 2018). "Signaling lymphocytic activation molecules Slam and cancers: friends or foes?". Oncotarget. 9 (22): 16248–16262. doi:10.18632/oncotarget.24575. PMC 5882332. PMID 29662641.
Dragovich MA, Mor A (July 2018). "The SLAM family receptors: Potential therapeutic targets for inflammatory and autoimmune diseases". Autoimmunity Reviews. 17 (7): 674–682. doi:10.1016/j.autrev.2018.01.018. PMC 6508580. PMID 29729453.
van Driel BJ, Liao G, Engel P, Terhorst C (2016-01-20). "Responses to Microbial Challenges by SLAMF Receptors". Frontiers in Immunology. 7: 4. doi:10.3389/fimmu.2016.00004. PMC 4718992. PMID 26834746.
de Vries RD, Duprex WP, de Swart RL (February 2015). "Morbillivirus infections: an introduction". Viruses. 7 (2): 699–706. doi:10.3390/v7020699. PMC 4353911. PMID 25685949.

semanticscholar.org (Global: 15^th place; English: 8^th place)

api.semanticscholar.org

Cocks BG, Chang CC, Carballido JM, Yssel H, de Vries JE, Aversa G (July 1995). "A novel receptor involved in T-cell activation". Nature. 376 (6537): 260–263. Bibcode:1995Natur.376..260C. doi:10.1038/376260a0. PMID 7617038. S2CID 4319295.
Gordiienko I, Shlapatska L, Kovalevska L, Sidorenko SP (July 2019). "SLAMF1/CD150 in hematologic malignancies: Silent marker or active player?". Clinical Immunology. 204: 14–22. doi:10.1016/j.clim.2018.10.015. PMID 30616923. S2CID 58586790.

zenodo.org (Global: 737^th place; English: 426^th place)

Gordiienko I, Shlapatska L, Kovalevska L, Sidorenko SP (July 2019). "SLAMF1/CD150 in hematologic malignancies: Silent marker or active player?". Clinical Immunology. 204: 14–22. doi:10.1016/j.clim.2018.10.015. PMID 30616923. S2CID 58586790.

SLAMF1 (English Wikipedia)

adsabs.harvard.edu (Global: 14th place; English: 9th place)

ui.adsabs.harvard.edu

doi.org (Global: 2nd place; English: 2nd place)

ensembl.org (Global: 630th place; English: 326th place)